BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 33395950)

  • 1. Human exposure pathways to poly- and perfluoroalkyl substances (PFAS) from indoor media: A systematic review protocol.
    DeLuca NM; Angrish M; Wilkins A; Thayer K; Cohen Hubal EA
    Environ Int; 2021 Jan; 146():106308. PubMed ID: 33395950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human exposure pathways to poly- and perfluoroalkyl substances (PFAS) from indoor media: A systematic review.
    DeLuca NM; Minucci JM; Mullikin A; Slover R; Cohen Hubal EA
    Environ Int; 2022 Apr; 162():107149. PubMed ID: 35240384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic Evidence Mapping of Potential Exposure Pathways for Per- and Polyfluoroalkyl Substances Based on Measured Occurrence in Multiple Media.
    Holder C; DeLuca N; Luh J; Alexander P; Minucci JM; Vallero DA; Thomas K; Cohen Hubal EA
    Environ Sci Technol; 2023 Apr; 57(13):5107-5116. PubMed ID: 36940151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomarkers of poly- and perfluoroalkyl substances (PFAS) in Sub-Arctic and Arctic communities in Canada.
    Garcia-Barrios J; Drysdale M; Ratelle M; Gaudreau É; LeBlanc A; Gamberg M; Laird BD
    Int J Hyg Environ Health; 2021 Jun; 235():113754. PubMed ID: 33984600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic review and meta-analysis of epidemiologic data on vaccine response in relation to exposure to five principal perfluoroalkyl substances.
    Crawford L; Halperin SA; Dzierlenga MW; Skidmore B; Linakis MW; Nakagawa S; Longnecker MP
    Environ Int; 2023 Feb; 172():107734. PubMed ID: 36764183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic evidence mapping of potential correlates of exposure for per- and poly-fluoroalkyl substances (PFAS) based on measured occurrence in biomatrices and surveys of dietary consumption and product use.
    Holder C; Cohen Hubal EA; Luh J; Lee MG; Melnyk LJ; Thomas K
    Int J Hyg Environ Health; 2024 Jun; 259():114384. PubMed ID: 38735219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristic and human exposure risk assessment of per- and polyfluoroalkyl substances: A study based on indoor dust and drinking water in China.
    Ao J; Yuan T; Xia H; Ma Y; Shen Z; Shi R; Tian Y; Zhang J; Ding W; Gao L; Zhao X; Yu X
    Environ Pollut; 2019 Nov; 254(Pt A):112873. PubMed ID: 31369910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perfluoroalkyl acids in pregnant women from Nunavik (Quebec, Canada): Trends in exposure and associations with country foods consumption.
    Caron-Beaudoin É; Ayotte P; Blanchette C; Muckle G; Avard E; Ricard S; Lemire M
    Environ Int; 2020 Dec; 145():106169. PubMed ID: 33041046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations of prenatal exposure to perfluoroalkyl substances with preterm birth: A family-based birth cohort study.
    Yu Y; Qin XD; Bloom MS; Chu C; Dai X; Li QQ; Chen ZX; Kong ML; Xie YQ; Meng WJ; Yang BY; Hu LW; Zeng XW; Zhao XM; Zhou Y; Dong GH
    Environ Res; 2022 Nov; 214(Pt 1):113803. PubMed ID: 35810818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Internal Relative Potency Factors for the Risk Assessment of Mixtures of Per- and Polyfluoroalkyl Substances (PFAS) in Human Biomonitoring.
    Bil W; Zeilmaker MJ; Bokkers BGH
    Environ Health Perspect; 2022 Jul; 130(7):77005. PubMed ID: 35881550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tap Water Contributions to Plasma Concentrations of Poly- and Perfluoroalkyl Substances (PFAS) in a Nationwide Prospective Cohort of U.S. Women.
    Hu XC; Tokranov AK; Liddie J; Zhang X; Grandjean P; Hart JE; Laden F; Sun Q; Yeung LWY; Sunderland EM
    Environ Health Perspect; 2019 Jun; 127(6):67006. PubMed ID: 31170009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Swimming with PFAS in public and private pools.
    Martinez B; Robey NM; Da Silva BF; Ditz H; Sobczak WJ; Deliz Quiñones KY; Bowden JA
    Chemosphere; 2023 Jan; 310():136765. PubMed ID: 36241119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the individual and combined toxicity of perfluoroalkyl substances to human liver cells using biomarkers of oxidative stress.
    Ojo AF; Xia Q; Peng C; Ng JC
    Chemosphere; 2021 Oct; 281():130808. PubMed ID: 34022600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimated daily intake of per- and polyfluoroalkyl substances related to different particle size fractions of house dust.
    Gustafsson Å; Bergman Å; Weiss JM
    Chemosphere; 2022 Sep; 303(Pt 2):135061. PubMed ID: 35649447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Association of Hypertension with Perfluoroalkyl and Polyfluoroalkyl Substances.
    Yang J; Zhang K; Shen C; Tang P; Tu S; Li J; Chen L; Yang W
    Int Heart J; 2023 Nov; 64(6):1079-1087. PubMed ID: 37967990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Legacy and alternative per- and polyfluoroalkyl substances in the U.S. general population: Paired serum-urine data from the 2013-2014 National Health and Nutrition Examination Survey.
    Calafat AM; Kato K; Hubbard K; Jia T; Botelho JC; Wong LY
    Environ Int; 2019 Oct; 131():105048. PubMed ID: 31376596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brominated flame retardants and perfluorinated compounds in indoor dust from homes and offices in Flanders, Belgium.
    D'Hollander W; Roosens L; Covaci A; Cornelis C; Reynders H; Campenhout KV; Voogt Pd; Bervoets L
    Chemosphere; 2010 Sep; 81(4):478-87. PubMed ID: 20709355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Legacy and alternative per- and polyfluoroalkyl substances (PFAS) alter the lipid profile of HepaRG cells.
    Kashobwe L; Sadrabadi F; Brunken L; Coelho ACMF; Sandanger TM; Braeuning A; Buhrke T; Öberg M; Hamers T; Leonards PEG
    Toxicology; 2024 Jun; 506():153862. PubMed ID: 38866127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomonitoring of emerging contaminants, perfluoroalkyl and polyfluoroalkyl substances (PFAS), in New Jersey adults in 2016-2018.
    Yu CH; Riker CD; Lu SE; Fan ZT
    Int J Hyg Environ Health; 2020 Jan; 223(1):34-44. PubMed ID: 31679856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.